Search
for
Sort by
Research 30 of 1000+
- Metabolic Syndrome, Hepatic Steatosis and Testosterone: A Matter of Sex
- Metabolism of finasteride in rat hepatic microsomes: Age and sex differences and effects of P450 inducers
- NAD⁺ Biology in Ageing and Chronic Disease: Mechanisms and Evidence across Skin, Fertility, Osteoarthritis, Hearing and Vision Loss, Gut Health, Cardiovascular–Hepatic Metabolism, Neurological Disorders, and Muscle
- Glyoxylic acid in hair straighteners: a critical evaluation of transdermal absorption and hepatic metabolism in nephrotoxicity risk assessment
- The Postnatal Offspring of Finasteride-Treated Male Rats Shows Hyperglycaemia, Elevated Hepatic Glycogen Storage and Altered GLUT2, IR, and AR Expression in the Liver
- Comprehensive Management of Polycystic Ovary Syndrome: The Role of Metformin in Addressing Metabolic and Endocrine Dysregulation
- Metabolic dysfunction in female mice with disruption of 5α-reductase 1
- Prevalence of hepatic steatosis in women with polycystic ovary syndrome
- Genetic ablation of myelin protein zero-like 3 in mice increases energy expenditure, improves glycemic control, and reduces hepatic lipid synthesis
- 5α-Reductase Type 1 Deficiency or Inhibition Predisposes to Insulin Resistance, Hepatic Steatosis, and Liver Fibrosis in Rodents
- Identification of hepatic molecular mechanisms of action of alpha-tocopherol using global gene expression profile analysis in rats
- Bioequivalence Study of Finasteride
- Chemistry, Pharmacology and Therapeutic Potential of Decursin: A Promising Natural Lead for New Drug Discovery and Development
- Resident macrophages of the lung and liver: The guardians of our tissues
- Cutaneous Clues in Systemic Disease: The Role of Dermatological Manifestations in Internal Medicine and Endocrinology
- Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome
- In vitro biotransformation of finasteride in rat hepatic microsomes. Isolation and characterization of metabolites.
- Preponderance of serum and intra-hepatic 5α-dihydrotestosterone in males with hepatocellular carcinoma despite low circulating androgen levels
- Effective amelioration of hepatic inflammation and insulin response in high fat diet-fed rats via regulating AKT/mTOR signaling: Role of Lepidium sativum seed extracts
- Cedrol mitigates hepatic lipid accumulation and adipocyte hypertrophy induced by corticosteroids through the inhibition of glucocorticoid receptor activity
- 5α-Reductase Type 2 Regulates Glucocorticoid Action and Metabolic Phenotype in Human Hepatocytes
- Dunnigan-Type Familial Partial Lipodystrophy: Understanding and Treating the Syndrome
- In vivo Pharmacokinetic Interactions of Finasteride and Identification of Novel Metabolites
- Metabolite screening of aromatic amine hair dyes using<i>in vitro</i>hepatic models
- GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
- Prospective metabolic evaluation of 150 consecutive patients who underwent gastric exclusion
- Skin and metabolic syndrome: A review of the possible associations
- Metabolic effects of 5α-reductase inhibition in humans
- Toxic and Metabolic Disorders of the Nervous System
- The application of optical technology in the diagnosis and therapy of oxidative stress-mediated hepatic ischemia-reperfusion injury